These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

701 related articles for article (PubMed ID: 28108677)

  • 1. In vitro susceptibility to 19 agents other than β-lactams among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission.
    Mischnik A; Baumert P; Hamprecht A; Rohde AM; Peter S; Feihl S; Knobloch J; Gölz H; Kola A; Obermann B; Querbach C; Willmann M; Gebhardt F; Tacconelli E; Gastmeier P; Seifert H; Kern WV;
    J Antimicrob Chemother; 2017 May; 72(5):1359-1363. PubMed ID: 28108677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of multidrug-resistant Enterobacteriaceae clinical isolates to tigecycline.
    Huang TD; Berhin C; Bogaerts P; Glupczynski Y
    J Antimicrob Chemother; 2012 Nov; 67(11):2696-9. PubMed ID: 22833638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic coresistance in extended-spectrum-beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline.
    Morosini MI; García-Castillo M; Coque TM; Valverde A; Novais A; Loza E; Baquero F; Cantón R
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2695-9. PubMed ID: 16870760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility and resistance phenotypes in contemporary Enterobacter isolates in a university hospital in Crete, Greece.
    Maraki S; Vardakas KZ; Samonis G; Perdikis D; Mavromanolaki VE; Kofteridis DP; Falagas ME
    Future Microbiol; 2017 Jun; 12():683-693. PubMed ID: 28540747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline.
    Livermore DM; Warner M; Mushtaq S; Doumith M; Zhang J; Woodford N
    Int J Antimicrob Agents; 2011 May; 37(5):415-9. PubMed ID: 21429716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains.
    Rodríguez-Avial I; Pena I; Picazo JJ; Rodríguez-Avial C; Culebras E
    Int J Antimicrob Agents; 2015 Dec; 46(6):616-21. PubMed ID: 26391381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plazomicin activity against polymyxin-resistant Enterobacteriaceae, including MCR-1-producing isolates.
    Denervaud-Tendon V; Poirel L; Connolly LE; Krause KM; Nordmann P
    J Antimicrob Chemother; 2017 Oct; 72(10):2787-2791. PubMed ID: 29091226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetic determinants of antibacterial resistance among nosocomial Escherichia coli, Klebsiella spp., and Enterobacter spp. isolates collected in Russia within 2003-2007].
    Priamchuk SD; Fursova NK; Abaev IV; Kovalev IuN; Shishkova NA; Pecherskikh EI; Korobova OV; Astashkin EI; Pachkunov DM; Kruglov AN; Ivanov DV; Sidorenko SV; Svetoch EA; Diatlov IA
    Antibiot Khimioter; 2010; 55(9-10):3-10. PubMed ID: 21400746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High frequency of co-resistance in CTX-M-producing Escherichia coli to non-beta-lactam antibiotics, with the exceptions of amikacin, nitrofurantoin, colistin, tigecycline, and fosfomycin, in a county of Sweden.
    Östholm Balkhed Å; Tärnberg M; Monstein HJ; Hällgren A; Hanberger H; Nilsson LE
    Scand J Infect Dis; 2013 Apr; 45(4):271-8. PubMed ID: 23113731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What Is the Appropriate Meropenem MIC for Screening of Carbapenemase-Producing Enterobacteriaceae in Low-Prevalence Settings?
    Fattouh R; Tijet N; McGeer A; Poutanen SM; Melano RG; Patel SN
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1556-9. PubMed ID: 26711746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK.
    Doumith M; Ellington MJ; Livermore DM; Woodford N
    J Antimicrob Chemother; 2009 Apr; 63(4):659-67. PubMed ID: 19233898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canadian survey of antimicrobial resistance in Klebsiella spp. and Enterobacter spp. The Canadian Antimicrobial Resistance Study Group.
    Toye BW; Scriver SR; Low DE
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():81-6. PubMed ID: 8150770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of tigecycline tested against a global collection of Enterobacteriaceae, including tetracycline-resistant isolates.
    Fritsche TR; Strabala PA; Sader HS; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):209-13. PubMed ID: 16105566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional variations in multidrug resistance among Enterobacteriaceae in the USA and comparative activity of tigecycline, a new glycylcycline antimicrobial.
    DiPersio JR; Dowzicky MJ
    Int J Antimicrob Agents; 2007 May; 29(5):518-27. PubMed ID: 17376657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
    Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confronting Ceftolozane-Tazobactam Susceptibility in Multidrug-Resistant Enterobacterales Isolates and Whole-Genome Sequencing Results (STEP Study).
    Hernández-García M; García-Fernández S; García-Castillo M; Melo-Cristino J; Pinto MF; Gonçalves E; Alves V; Costa E; Ramalheira E; Sancho L; Diogo J; Ferreira R; Silva T; Chaves C; Pássaro L; Paixão L; Romano J; Cantón R;
    Int J Antimicrob Agents; 2021 Feb; 57(2):106259. PubMed ID: 33310115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic & molecular characterization of AmpC β-lactamases among Escherichia coli, Klebsiella spp. & Enterobacter spp. from five Indian Medical Centers.
    Manoharan A; Sugumar M; Kumar A; Jose H; Mathai D; Khilnani GC; Kapil A; Francis G; Radhakrishnan K; Dutta TK; Parija SC; Narang R; Mendiratta DK; Deotale V; Baronia AK; Prasad KN
    Indian J Med Res; 2012 Mar; 135(3):359-64. PubMed ID: 22561623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, Greece.
    Galani I; Souli M; Daikos GL; Chrysouli Z; Poulakou G; Psichogiou M; Panagea T; Argyropoulou A; Stefanou I; Plakias G; Giamarellou H; Petrikkos G
    J Chemother; 2012 Aug; 24(4):191-4. PubMed ID: 23040681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enterobacter and Klebsiella species isolated from fresh vegetables marketed in Valencia (Spain) and their clinically relevant resistances to chemotherapeutic agents.
    Falomir MP; Rico H; Gozalbo D
    Foodborne Pathog Dis; 2013 Dec; 10(12):1002-7. PubMed ID: 23980710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of important Gram-negative pathogens to tigecycline and other antibiotics in Latin America between 2004 and 2010.
    Fernández-Canigia L; Dowzicky MJ
    Ann Clin Microbiol Antimicrob; 2012 Oct; 11():29. PubMed ID: 23088592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.